Are you Dr. Cortese?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 41 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
600 N Wolfe St
Room 5b12
Baltimore, MD 21287Phone+1 410-955-6626- Is this information wrong?
Summary
- Dr. Irene Cortese, MD is a board certified neurologist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland.
Education & Training
Johns Hopkins UniversityFellowship, Clinical Neurophysiology, 2005 - 2007- Johns Hopkins UniversityResidency, Neurology, 2002 - 2005
- Johns Hopkins UniversityResidency, Internal Medicine, 2001 - 2002
Certifications & Licensure
MD State Medical License 2005 - 2024- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Manganese-Enhanced Magnetic Resonance Imaging in Healthy Volunteers and People With Multiple Sclerosis Start of enrollment: 2013 Oct 17
- Adoptive Cellular Immunotherapy for Progressive Multifocal Leukoencephalopathy With Ex Vivo Generated Polyomavirus-Specific T-Cells Start of enrollment: 2016 Mar 28
- Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques Start of enrollment: 2016 Oct 05
Publications & Presentations
PubMed
- The neuroradiology of progressive multifocal leukoencephalopathy: a clinical trial perspective.Laura E Baldassari, Mike P. Wattjes, Irene Cortese, Achim Gass, Imke Metz, Tarek A. Yousry, Daniel S. Reich, Nancy Richert> ;Brain. 2021 Nov 16
- 5 citationsClinical trial of raltegravir, an integrase inhibitor, in HAM/TSP.Yoshimi Enose-Akahata, Bridgette Jeanne Billioux, Shila Azodi, Jennifer E. Dwyer, Ashley Vellucci, Nyater Ngouth, Satoshi Nozuma, Raya Massoud, Irene Cortese, Joan Oha...> ;Annals of Clinical and Translational Neurology. 2021 Sep 25
- 23 citationsSASH3 variants cause a novel form of X-linked combined immunodeficiency with immune dysregulation, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Blood. 2021 Sep 23
- Join now to see all
Press Mentions
NeoImmuneTech Announces First Patient Dosed in the Pilot Study of NT-I7 (Efineptakin Alfa) in Progressive Multifocal LeukoencephalopathyMay 24th, 2021- NeoImmuneTech Receives U.S. FDA IND Clearance for Pilot Study of NT-I7 (Efineptakin Alfa) in Progressive Multifocal LeukoencephalopathyFebruary 23rd, 2021
Progressive Multifocal Leukoencephalopathy and the Spectrum of JC Virus-Related DiseaseNovember 20th, 2020- Join now to see all
